Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Tsutsui K, Kanbayashi T, Tanaka K, Boku S, Ito W, Tokunaga J, Mori A, Hishikawa Y, Shimizu T, Nishino S.

BMC Psychiatry. 2012 May 8;12:37. doi: 10.1186/1471-244X-12-37.

2.

Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.

Ando Y, Shimazaki H, Shiota K, Tetsuka S, Nakao K, Shimada T, Kurata K, Kuroda J, Yamashita A, Sato H, Sato M, Eto S, Onishi Y, Tanaka K, Kato S.

BMC Psychiatry. 2016 Jul 8;16:226. doi: 10.1186/s12888-016-0948-9.

3.

[Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].

Iizuka T, Sakai F.

Brain Nerve. 2008 Sep;60(9):1047-60. Review. Japanese.

PMID:
18807939
4.

Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.

Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A.

Psychosomatics. 2015 May-Jun;56(3):227-41. doi: 10.1016/j.psym.2015.01.003. Epub 2015 Feb 4.

PMID:
25975857
5.

Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.

Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J.

JAMA Neurol. 2013 Sep 1;70(9):1133-9.

6.

Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.

Kayser MS, Dalmau J.

Schizophr Res. 2016 Sep;176(1):36-40. doi: 10.1016/j.schres.2014.10.007. Epub 2014 Oct 25. Review.

7.

Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.

Liu CY, Zhu J, Zheng XY, Ma C, Wang X.

Mediators Inflamm. 2017;2017:6361479. doi: 10.1155/2017/6361479. Epub 2017 Jun 18. Review.

8.

Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis.

Pollak TA, McCormack R, Peakman M, Nicholson TR, David AS.

Psychol Med. 2014 Sep;44(12):2475-87. doi: 10.1017/S003329171300295X. Epub 2013 Dec 13. Review. Erratum in: Psychol Med. 2014 Sep;44(12):2488.

PMID:
24330811
9.

[Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia].

Le Guen E, Doukhan R, Hamdani N, Tamouza R, Groc L, Honnorat J, Leboyer M.

Med Sci (Paris). 2015 Jan;31(1):60-7. doi: 10.1051/medsci/20153101014. Epub 2015 Feb 6. Review. French.

10.

Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J.

Ann Neurol. 2014 Mar;75(3):411-28.

11.

Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.

Schou M, Sæther SG, Borowski K, Teegen B, Kondziella D, Stoecker W, Vaaler A, Reitan SK.

Psychol Med. 2016 Dec;46(16):3303-3313. Epub 2016 Sep 9.

PMID:
27609625
12.

Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases.

Cundiff CA, Elawabdeh N, Naguib MM, Jactel SN, Demellawy DE, Abramowsky CR, Durham MM, Youssef L, Wittkamp ML, Shehata BM.

Pediatr Dev Pathol. 2015 Mar-Apr;18(2):122-6. doi: 10.2350/14-09-1554-OA.1. Epub 2015 Jan 8.

PMID:
25569473
13.

[Anti-NMDA Receptor Antibody-Related Encephalitis].

Nagayama S, Tanaka K.

Brain Nerve. 2016 Sep;68(9):1001-1009. Japanese.

PMID:
27667486
14.

Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report.

Kramina S, Kevere L, Bezborodovs N, Purvina S, Rozentals G, Strautmanis J, Viksna Z.

Psych J. 2015 Dec;4(4):226-30. doi: 10.1002/pchj.121.

PMID:
26663628
15.

Abnormal neurons in teratomas in NMDAR encephalitis.

Day GS, Laiq S, Tang-Wai DF, Munoz DG.

JAMA Neurol. 2014 Jun;71(6):717-24. doi: 10.1001/jamaneurol.2014.488.

PMID:
24781184
16.

[Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture].

Prüss H, Dalmau J, Arolt V, Wandinger KP.

Nervenarzt. 2010 Apr;81(4):396, 398, 400, passim. doi: 10.1007/s00115-009-2908-9. Review. German.

PMID:
20119656
17.

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stoecker W.

JAMA Psychiatry. 2013 Mar;70(3):271-8. doi: 10.1001/2013.jamapsychiatry.86.

PMID:
23344076
18.

Anti-NMDAR encephalitis after resection of melanocytic nevi: report of two cases.

Yang XZ, Cui LY, Ren HT, Qu T, Guan HZ.

BMC Neurol. 2015 Sep 14;15:165. doi: 10.1186/s12883-015-0424-z.

19.

Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients.

Wang J, Zhang B, Zhang M, Chen J, Deng H, Wang Q, Sun X.

Neuropsychobiology. 2017;75(2):72-80. doi: 10.1159/000480514. Epub 2017 Oct 24.

PMID:
29065417
20.

[Clinical features and pathogenesis of anti-NMDA receptor encephalitis].

Iizuka T.

Rinsho Shinkeigaku. 2008 Nov;48(11):920-2. Review. Japanese.

PMID:
19198118

Supplemental Content

Support Center